STOCK TITAN

Octave Specialty Group (OSG) CEO and director reports 12,000-share insider purchase

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Octave Specialty Group Inc. director and Chief Executive Officer reported buying additional company stock. On 01/02/2026, a Form 4 shows an open-market purchase of 12,000 shares of common stock at a price of $7.59 per share, coded as an acquisition transaction. After this trade, the reporting person beneficially owns 1,033,777 shares of Octave Specialty Group Inc. common stock in direct ownership. The filing reflects a single, straightforward insider purchase with no derivative securities activity disclosed.

Positive

  • None.

Negative

  • None.
Insider LeBlanc Claude
Role Chief Executive Officer
Bought 12,000 shs ($91K)
Type Security Shares Price Value
Purchase Common Stock 12,000 $7.59 $91K
Holdings After Transaction: Common Stock — 1,033,777 shares (Direct)
Footnotes (1)
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LeBlanc Claude

(Last) (First) (Middle)
C/O OCTAVE SPECIALTY GROUP, INC.
40 WALL STREET, 55TH FLOOR

(Street)
NEW YORK NY 10005

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OCTAVE SPECIALTY GROUP INC [ OSG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 P 12,000 A $7.59 1,033,777 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
William White, attorney-in-fact 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Octave Specialty Group Inc (OSG) report?

The filing reports that a director and Chief Executive Officer of Octave Specialty Group Inc. acquired 12,000 shares of the company’s common stock in a single transaction.

On what date did the Octave Specialty Group Inc (OSG) insider buy shares?

The insider purchase took place on 01/02/2026, as disclosed in Table I of the Form 4.

What price did the Octave Specialty Group Inc (OSG) insider pay per share?

The director and Chief Executive Officer bought the common stock at a price of $7.59 per share.

How many Octave Specialty Group Inc (OSG) shares does the insider own after the transaction?

Following the reported transaction, the insider beneficially owns 1,033,777 shares of Octave Specialty Group Inc. common stock.

Is the reported Octave Specialty Group Inc (OSG) insider ownership direct or indirect?

The Form 4 identifies the 1,033,777 shares of common stock as held with direct (D) ownership.

Were any derivative securities reported for the Octave Specialty Group Inc (OSG) insider?

Table II for derivative securities is present but contains no entries, indicating no derivative transactions were reported in this filing.

Who signed the Octave Specialty Group Inc (OSG) Form 4?

The Form 4 was signed by William White as attorney-in-fact for the reporting person on 01/05/2026.